In this virtual event held by the Chamber of Commerce, Wistar’s Associate Dean of Biomedical Studies Dr. David Zuzga spoke about workforce development and the value of apprenticeship programs at th…
Newly published research identifies a mutation associated with scarring of the lungs, revealing a useful diagnostic tool and target for gene therapy. Idiopathic pulmonary fibrosis (IPF) is a fatal …
Newly published research identifies proteins in EBV-infected cells that decreased expression of genes linked to the spread of the virus, a fresh direction for EBV research. Epstein-Barr virus is a …
Dr. Luis Montaner, Wistar’s Associate Director for Shared Resources, and Mark Drinker, Wistar’s Associate Director for Administration of the Ellen and Ronald Caplan Cancer Center, chat about core f…
From historic machinery in one of our own investigator’s personal collection to the modern technology transforming Wistar research today, microscopes have helped Wistar scientists and researchers a…
From HIV to COVID-19, Wistar scientists are at the forefront of vaccine development. Read our recap of the recent Vaccine Symposium and the impactful research in progress at the Institute. This pas…
Wistar’s Drs. Kristy Shuda McGuire, dean of biomedical studies, and David Zuzga, associate dean of biomedical studies, spent an evening with students at Vaux Big Picture High School in north centra…
Dr. Diana Bautista has dedicated her professional life to the science of literal human connection: our sense of touch. A Howard Hughes Medical Investigator and professor of cell and developmental b…
Damaged “ghost” mitochondria are found to drive tumor progression. Metastasis, or the spread of cancer from one place in the body to another, is responsible for more than 90% of all cancer deaths. …
For the first time, scientists have developed an DNA-encoded immunogen that produces Tier-2 antibodies—the kind that matter for combatting HIV Nearly four decades after its discovery, HIV has kille…
